P16INK4a immunohistochemistry improves the reproducibility of the histological diagnosis of cervical intraepithelial neoplasia in cone biopsies

Gynecologic Oncology

Volumn 111, Issue 1, 2008, Pages 120-124

  Gurrola Díaz, Carmen M ^a   Suárez Rincón, Ángel E ^b   Vázquez Camacho, Gonzalo ^b   Buonocunto Vázquez, Giuseppe ^b   Rosales Quintana, Sergio ^b   Wentzensen, Nicolas ^c   von Knebel Doeberitz, Magnus ^c  

^a UNIVERSITY OF GUADALAJARA   (Mexico)

^b INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Biomarker; Cervical intraepithelial neoplasia (CIN); Immunohistochemistry; Mexico; p16 protein p16INK4a (cyclin dependent kinase inhibitor); Reproducibility

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; EOSIN; HEMATOXYLIN; TUMOR MARKER;

ADULT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REPRODUCIBILITY; TUMOR BIOPSY; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA IN SITU; CANCER STAGING; CHEMISTRY; METABOLISM; METHODOLOGY; OBSERVER VARIATION; PATHOLOGY; STAINING; UTERINE CERVIX CONIZATION; UTERINE CERVIX TUMOR;

ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; CONIZATION; CYCLIN-DEPENDENT KINASE INHIBITOR P16; EOSINE YELLOWISH-(YS); FEMALE; HEMATOXYLIN; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM STAGING; OBSERVER VARIATION; REPRODUCIBILITY OF RESULTS; STAINING AND LABELING; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 52049121496     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2008.06.032     Document Type: Article

References (25)

1. Dirección General de Información en Salud, Secretaría de Salud, México. Mexico's mortality statistics. Deaths registered in 2003. Salud Publica Mex 2005; 47:171-87.
2. Norma Oficial Mexicana (1994) and last modification, available from: http://www.hgm.sald.gob.mx/servmed/nom_014_zssa2_1994.pdf and http://www.salud.gob.mx/unidades/cdi/nom/m014ssa24.html Accessed 4 June 2007.
3. McCluggage W.G., Bharucha H., Caughley L.M., et al. Interobserver variation in the reporting of cervical colposcopic biopsy specimens: comparison of grading systems. J. Clin. Pathol. 49 (1996) 833-835
4. Stoler M.H., Schiffman M., and Atypical Squamous Cells of Undetermined Significance-Low-grade Squamous Intraepithelial Lesion Triage Study (ALTS) Group. Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study. JAMA 285 (2001) 1500-1505
5. Shutter J., Atkins K.A., Ghartey K., et al. Clinical applications of immunohistochemistry in gynecological malignancies. Int. J. Gynecol. Cancer 17 (2007) 311-315
6. Sano T., Masuda N., Oyama T., et al. Overexpression of p16 and p14ARF isassociated with human papillomavirus infection in cervical squamous cell carcinoma and dysplasia. Pathol. Int. 52 (2002) 375-383
7. Klaes R., Friedrich T., Spitkovsky D., et al. Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int. J. Cancer 92 (2001) 276-284
8. von-Knebel-Doeberitz M. New markers for cervical dysplasia to visualise the genomic chaos created by aberrant oncogenic papillomavirus infections. Eur. J. Cancer 38 (2002) 2229-2242
9. Carozzi F., Cecchini S., Confortini M., et al. Role of P16(INK4a) expressioninidentifying CIN2 or more severe lesions among HPV-positive patients referred for colposcopy after abnormal cytology. Cancer 108 (2006) 119-123
10. INK4a immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia. Am. J. Surg. Pathol. 26 (2002) 1389-1399
11. Richart R.M. Natural history of cervical intraepithelial neoplasia. Clin. Obstet. Gynecol. 10 (1967) 748-784
12. Miller A.B., Nazeer S., Fonn S., et al. Report on consensus conference on cervical cancer screening and management. Int. J. Cancer 86 (2000) 440-447
13. Landis J.R., and Koch G.G. The measurement of observer agreement for categorical data. Biometrics 33 (1977) 159-174
14. McCluggage W.G., Walsh M.Y., Thornton C.M., et al. Inter- and intra-observer variation in the histopathological reporting of cervical squamous intraepithelial lesions using a modified Bethesda grading system. Br. J. Obstet. Gynaecol. 105 (1998) 206-210
15. de-Ruiz P.A., Lazcano-Ponce E.C., Duarte-Torres R., et al. Diagnostic reproducibility of Pap testing in two regions of Mexico: the need for quality control mechanisms. Bull. Pan. Am. Health Organ. 30 (1996) 330-338
16. Lazcano-Ponce E.C., de-Ruiz P.A., Martinez-Arias C., et al. Diagnostic concordance in gynecologic cytology. Rev. Invest. Clin. 49 (1997) 111-116
17. Lazcano-Ponce E.C., AlonsodeRuiz P., Lopez-Carrillo L., et al. Validity and reproducibility of cytologic diagnosis in a sample of cervical cancer screening centers in Mexico. Acta. Cytol. 41 (1997) 277-284
18. Lazcano-Ponce E.C., Alonso de Ruiz P., Martinez-Arias C., et al. Reproducibility study of cervical cytopathology in Mexico: a need for regulation and professional accreditation. Diagn. Cytopathol. 17 (1997) 20-24
19. Holowaty P., Miller A.B., Rohan T., et al. Natural history of dysplasia of the uterine cervix. J. Natl. Cancer. Inst. 91 (1999) 252-258
20. Ismail S.M., Colclough A.B., Dinnen J.S., et al. Observer variation in histopathological diagnosis and grading of cervical intraepithelial neoplasia. BMJ 298 (1989) 707-710
21. Robertson A.J., Anderson J.M., Beck J.S., et al. Observer variability in histopathological reporting of cervical biopsy specimens. J. Clin. Pathol. 42 (1989) 231-238
22. Negri G., Vittadello F., Romano F., et al. p16INK4a expression and progression risk of low-grade intraepithelial neoplasia of the cervix uteri. Virchows Arch. 445 (2004) 616-620
23. Walter S.D. Measuring the reliability of clinical data: the case for using three observers. Rev. Epidemiol. Sante Publique 32 (1984) 206-211
24. Zhang Q., Kuhn L., Denny L.A., et al. Impact of utilizing p16INK4A immunohistochemistry on estimated performance of three cervical cancer screening tests. Int. J. Cancer 120 (2007) 351-356
25. Ekalaksananan T., Pientong C., Sriamporn S., et al. Usefulness of combining testing for p16 protein and human papillomavirus (HPV) in cervical carcinoma screening. Gynecol. Oncol. 103 (2006) 62-66